How does Burna AI address the 11% oncology death rate attributable to poor adverse event management?

The 11% figure is an industry estimate of oncology deaths attributable to poor adverse event management. Burna AI works on three points where adverse events are recognized and recorded. At the encounter, each event is graded on CTCAE and scored for attribution against every drug in the regimen, with the evidence from the record attached, so the investigator decides with the reasoning in view. Between visits, trial participants report symptoms in their own words through Healthnotes, and those reports reach the next graded encounter as evidence for the investigator. Across sites, sponsors read graded safety data for their own trials from the same signed record the sites work in. AI suggests, clinicians decide.